ATE277063T1 - 6-o-alkylerythromycinoxim b - Google Patents

6-o-alkylerythromycinoxim b

Info

Publication number
ATE277063T1
ATE277063T1 AT98958055T AT98958055T ATE277063T1 AT E277063 T1 ATE277063 T1 AT E277063T1 AT 98958055 T AT98958055 T AT 98958055T AT 98958055 T AT98958055 T AT 98958055T AT E277063 T1 ATE277063 T1 AT E277063T1
Authority
AT
Austria
Prior art keywords
oxime erythromycin
alkyl
alkylerythromycinoxime
alkyl derivative
erythromycin
Prior art date
Application number
AT98958055T
Other languages
English (en)
Inventor
Stephen H Montgomery
Jih-Hua Liu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE277063T1 publication Critical patent/ATE277063T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
AT98958055T 1997-12-01 1998-11-17 6-o-alkylerythromycinoxim b ATE277063T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/980,918 US5932710A (en) 1997-12-01 1997-12-01 Process for preparing 6-O-alkyl-9-oxime erythromycin B
PCT/US1998/024547 WO1999028332A1 (en) 1997-12-01 1998-11-17 6-o-alkyl erythromycin b oxime

Publications (1)

Publication Number Publication Date
ATE277063T1 true ATE277063T1 (de) 2004-10-15

Family

ID=25527956

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98958055T ATE277063T1 (de) 1997-12-01 1998-11-17 6-o-alkylerythromycinoxim b

Country Status (13)

Country Link
US (2) US5932710A (de)
EP (1) EP1042340B1 (de)
JP (1) JP2001525331A (de)
KR (1) KR20010032688A (de)
AT (1) ATE277063T1 (de)
AU (1) AU1417399A (de)
CA (1) CA2309963C (de)
DE (1) DE69826520T2 (de)
DK (1) DK1042340T3 (de)
ES (1) ES2229550T3 (de)
IL (1) IL136088A0 (de)
PT (1) PT1042340E (de)
WO (1) WO1999028332A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1254146B1 (de) * 1999-12-16 2005-08-24 Teva Pharmaceutical Industries Ltd. Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
PL356645A1 (en) 2000-01-11 2004-06-28 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
CZ20023167A3 (cs) 2000-02-29 2003-10-15 Teva Pharmaceutical Industries Ltd. Způsob přípravy klaritromycinu a klaritromycinového meziproduktu, v podstatě prostého oximu a farmaceutický prostředek, který jej obsahuje
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6455680B1 (en) 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1658034A4 (de) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
JPWO2007119717A1 (ja) * 2006-04-13 2009-08-27 大正製薬株式会社 アルドヘキソピラノース中間体の製造法
WO2007129646A1 (ja) * 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. マクロライド誘導体
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2177526A4 (de) 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd An position 10a und position 12 vernetzte 10a-azalidverbindung
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin
WO2009139181A1 (ja) 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
CN102082088B (zh) * 2009-11-30 2012-04-18 上海华虹Nec电子有限公司 在直接化学机械抛光工艺的产品中共用sl掩模板的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681326A (en) * 1971-01-11 1972-08-01 Abbott Lab 9-substituted erythromycin a and b oximes
US3855203A (en) * 1973-05-03 1974-12-17 Abbott Lab 4{41 -o-sulfonyl erythromycin-9-o-oxime derivatives
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
IL104437A (en) * 1992-01-21 1997-03-18 Abbott Lab 4)-deoxyerythromycin derivatives

Also Published As

Publication number Publication date
ES2229550T3 (es) 2005-04-16
KR20010032688A (ko) 2001-04-25
EP1042340A1 (de) 2000-10-11
AU1417399A (en) 1999-06-16
DE69826520T2 (de) 2005-12-01
EP1042340B1 (de) 2004-09-22
CA2309963A1 (en) 1999-06-10
CA2309963C (en) 2008-06-17
DE69826520D1 (en) 2004-10-28
US5932710A (en) 1999-08-03
DK1042340T3 (da) 2004-11-29
IL136088A0 (en) 2001-05-20
WO1999028332A1 (en) 1999-06-10
JP2001525331A (ja) 2001-12-11
PT1042340E (pt) 2004-12-31
US6194387B1 (en) 2001-02-27

Similar Documents

Publication Publication Date Title
DK1042340T3 (da) 6-O-alkylerythromycinoxim-B
DK0891371T3 (da) 9-oximsilylerythromycin A derivater
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
EE03263B1 (et) Erütromütsiini derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja vaheühendid
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
ZA9710796B (en) Oxyiminopregnanecarbolactones.
NZ337246A (en) Pharmaceutical composition comprising amoxycillin and clavulanate
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
ATE71113T1 (de) Antibiotikum a 40926 mannosyl aglycon.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DK312688D0 (da) Glykkopeptid-antibiotika
IS6559A (is) Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
AP9801377A0 (en) Tricyclic erythromycin derivatives.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
LV12172A (lv) Kompozicija organu kriokonservesanai um virusu un bakterialas infekcijas arstesanai
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
AP9801235A0 (en) Erythromycin derivatives.
ZA9711101B (en) Derivatives of erythromycin their preparation process and their use as medicaments
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
NO178302C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte 3-tia- henholdsvis 3-oksa-alkylflavoner, samt mellomprodukter for fremgangsmåten
AU4272596A (en) Production process of the ecological pharmaceutical compositions in the veterinary medical field
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
IT1199965B (it) Peptide,procedimento microbiologico per la sua produzione e suo impiego come agente antibiotico,citotossico e fitotossico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1042340

Country of ref document: EP

REN Ceased due to non-payment of the annual fee